Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments TrialsJuan E. Grunwald, Daniel Martín, Alison Martin et al.|Ophthalmology|2013Cited by 585
Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular DegenerationGui‐Shuang Ying, Daniel Martín, Jiayan Huang et al.|Ophthalmology|2012Cited by 310
Discrete expression and distribution pattern of TIMP-3 in the human retina and choroidJanice A. Vranka, Ted S. Acott, Elaine C. Johnson et al.|Current Eye Research|1997Cited by 62
Malattia leventinese: refinement of the genetic locus and phenotypic variability in autosomal dominant macular drusenAlbert O. Edwards, Ted S. Acott, Michael L. Klein et al.|American Journal of Ophthalmology|1998Cited by 29